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Abstract  30 
Cut-and-paste DNA transposons of the mariner/Tc1 family are useful tools for genome engineering and 31 
are inserted specifically at TA target sites. A crystal structure of the mariner transposase Mos1 (derived 32 
from Drosophila mauritiana), in complex with transposon ends covalently joined to target DNA, portrays 33 
the transposition machinery after DNA integration. It reveals severe distortion of target DNA and flipping 34 
of the target adenines into extra-helical positions. Fluorescence experiments confirm dynamic base 35 
flipping in solution. Transposase residues W159, R186, F187 and K190 stabilise the target DNA 36 
distortions and are required for efficient transposon integration and transposition in vitro. Transposase 37 
recognises the flipped target adenines via base-specific interactions with backbone atoms, offering a 38 
molecular basis for TA target sequence selection. Our results will provide a template for re-designing 39 
mariner/Tc1 transposases with modified target specificities.  40 
 41 
Impact Statement 42 
Structural and biochemical analyses of a eukaryotic DNA transpososome in the integration step reveal, in 43 
molecular detail, how mariner/Tc1 transposons are selectively integrated into a TA target sequence. 44 
 45 
Introduction 46 
Transposable elements are ubiquitous in most genomes and promote evolution by generating genetic 47 
diversity (Biemont and Vieira, 2006). Invading transposons can alter genes, affect gene expression or 48 
spread drug resistance in bacteria. As shuffling of DNA by transposition can be deleterious, transposons 49 
often become inactivated or transcriptionally silenced. Conversely, transposons can give rise to new, 50 
useful cell functions. For example, domestication of a Transib-type DNA transposon led to V(D)J 51 
recombination and adaptive immunity in jawed vertebrates (Kapitonov and Jurka, 2005). Similarly, the 52 
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Cas1 integrase component of prokaryotic CRISPR-Cas systems of adaptive immunity originated from DNA 53 
transposons named Casposons (Krupovic et al., 2014).  Integration of spacer sequences into the CRISPR 54 
locus by the Cas1-Cas2 complex has similarities with transposon and retroviral DNA integration (Nunez et 55 
al., 2015). 56 
 57 
DNA transposons move from one genomic location to another using transposon-encoded recombinases, 58 
often by a DNA cut-and-paste mechanism. Many DNA transposases (e.g. Mos1, Tn5 and bacteriophage 59 
MuA) share a conserved RNase H-like catalytic domain, along with retroviral integrases (e.g. HIV-1) and 60 
RAG recombinases. These DDE/D enzymes use common active site chemistry to perform similar DNA 61 
cleavage and DNA integration reactions. By contrast, there is wide diversity in their preferred target 62 
integration sites. Most DDE/D recombinases show only limited preference for a consensus target DNA 63 
sequence, which is usually palindromic (Goryshin et al., 1998, Halling and Kleckner, 1982). The number of 64 
base pairs separating the integration sites on complementary DNA strands also varies, from 2 to 9. Some 65 
retroviral integrases (e.g. prototype foamy virus (PFV) and HIV-1) preferentially insert their viral genome 66 
into nucleosomal DNA (Pruss et al., 1994, Maskell et al., 2015). Similarly, some transposases (e.g. Tn10) 67 
favour bent target DNA structures (Pribil and Haniford, 2003).  In other transposition systems (e.g. IS21, 68 
Mu), an element-encoded accessory ATPase facilitates strand transfer (Mizuno et al., 2013, Arias-Palomo 69 
and Berger, 2015); and can prevent self-destructive insertion of the transposon into its own sequence 70 
(target immunity), (Mizuno et al., 2013). Despite this biochemical knowledge, the molecular and 71 
structural origins for transposon target specificities remain unknown. 72 
 73 
Mariner/Tc1/IS630 family transposases are unusual as they integrate their transposons, with a 2 bp 74 
stagger, strictly at TA target sequences (Tellier et al., 2015). They are widespread in nature and are used 75 
as tools for genome engineering and therapeutic applications. For example, the reconstructed Tc1 76 
transposase Sleeping Beauty (Ivics et al., 1997) is being used in human clinical trials to treat B-cell 77 
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lymphoma by genetic engineering of T cells (Maiti et al., 2013) and in pre-clinical studies to reduce age-78 
related macular degeneration (Johnen et al., 2012). Up to 45 kb of DNA can be inserted into the C. 79 
elegans genome using a transposition system engineered from the mariner transposon Mos1 from 80 
Drosophila mauritiana (Frokjaer-Jensen et al., 2014). The ability to pre-select specific sites for 81 
integration, beyond the requisite TA, may be desirable for certain genome engineering applications, e.g. 82 
controlled genomic integration of a therapeutic gene.  Such targeted transposition has been achieved for 83 
the bacterial transposase ISY100 using a C-terminal Zif268 DNA-binding domain fusion (Feng et al., 2010); 84 
and for Sleeping Beauty transposase either by fusing it with a targeting domain (Yant et al., 2007) or by 85 
exploiting interactions with a targeting protein (Ivics et al., 2007).  Conversely, it may be useful to 86 
randomise mariner/Tc1 integrations; for example in whole genome sequencing applications as an 87 
alternative to Tn5 (Amini et al., 2014). Understanding in molecular detail how mariner/Tc1 transposons 88 
are integrated at TA target sites will aid development of these elements as genome engineering tools.  89 
 90 
The wealth of structural and biochemical data for the naturally active, eukaryotic transposon Mos1 offers 91 
a paradigm for determining the molecular mechanism of mariner/Tc1 transposon integration. The 1286 92 
bp transposon is framed by 28 bp imperfect inverted repeats (IR) (Jacobson et al., 1986) and encodes a 93 
345 amino acid transposase that can perform cut-and-paste DNA transposition in vitro (Lampe et al., 94 
1996), as shown in Figure 1a. The Mos1 transposase homodimer binds to the IR at one transposon end 95 
(Cuypers et al., 2013) and then captures the other IR, forming a paired-end complex (PEC). The trans 96 
architecture of the PEC regulates coordinated excision of the transposon ends (Richardson et al., 2009) 97 
and cross-talk between transposase sub-units (Bouuaert et al., 2014, Dornan et al., 2015). After excision, 98 
the Mos1 transpososome locates a TA target integration site (Pflieger et al., 2014) and, upon binding, 99 
forms a target capture complex (TCC) (Figure 1a). Attack by the 3'-OH at each transposon end on the 100 
phosphodiester 5' of the TA dinucleotide joins the excised transposon to the target site, in the DNA 101 
strand transfer reaction (Figure 1a,b). The DNA product of transposition, which contains a gap at each 102 
transposon end, is bound to the transposase in a strand transfer complex (STC). 103 
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 104 
To establish how mariner/Tc1 transposases recognize and integrate transposon DNA at a TA 105 
dinucleotide, we determined a crystal structure of the Mos1 STC. In this snapshot of the transposition 106 
machinery after DNA transposon integration, the target DNA is distorted from B-form and the target 107 
adenines are flipped into extra-helical positions. Base-flipping is confirmed in solution by time-resolved 108 
fluorescence of strand transfer complexes in which the target adenines are substituted by 2-109 
aminopurine. Adenine-specific interactions, between the flipped adenine bases and transposase 110 
backbone atoms, provide a molecular basis for recognition of the TA target sequence. Interactions with 111 
Mos1 transposase residues W159, R186, F187 and K190, which are essential for transposon integration 112 
in vitro, stabilise distortions in the target DNA.  Conservation of key residues involved in stabilising the 113 
target DNA distortions suggests this mechanism may also occur with other mariner/Tc1 family 114 
transposons. 115 
 116 
Results  117 
Crystallisation of the Mos1 strand transfer complex  118 
To assemble the Mos1 STC, full length T216A Mos1 transposase was combined, in a 1:1 molar ratio, with 119 
DNA representing the product of transposon integration (Figure 1c). This DNA contains the transposon IR 120 
joined at its 3' end to an unpaired TA dinucleotide and target DNA (Table 1). The bottom target DNA 121 
strand (strand b, magenta, Figure 1c) has a cohesive 4 nt 5' overhang (sequence GGCC) to promote 122 
interactions between adjacent complexes in the crystal lattice. This approach, of assembling the STC 123 
using the strand transfer product, and bypassing catalysis of integration, proved successful for the 124 
preparation of bona fide PFV strand transfer complexes (Yin et al., 2012).  125 
 126 
Mos1 STC crystals diffracted X-rays to a maximum resolution of 3.3 Å. Crystallographic phases were 127 
determined by molecular replacement (Materials and methods). The difference electron density after 128 
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molecular replacement and before model building is shown in Figure 2 – figure supplement 1). The 129 
crystallographic asymmetric unit contains one Mos1 STC and, as predicted, base pairing of the 4 nt 130 
overhangs in adjacent complexes facilitates crystal packing (Figure 2 – figure supplement 2). The refined 131 
model has an R(free) of 27.9% and good stereochemistry. The X-ray diffraction and refinement statistics 132 
are shown in Table 2.  133 
 134 
 135 
Architecture of the Mos1 strand transfer complex  136 
The refined Mos1 STC crystal structure (Figure 2a) contains a transposase homodimer bound to two DNA 137 
duplexes representing the products of transposon integration. Target DNA binds in a channel between 138 
the two catalytic domains and the active sites contain the strand transfer products. As the TCC also 139 
contains a transposase dimer (Pflieger et al., 2014), our new STC structure indicates that Mos1 strand 140 
transfer, like transposon excision,  is catalysed by a transposase dimer.  141 
 142 
The transposase subunits adopt a crossed (or trans) arrangement with IR DNA in the Mos1 STC, similar to 143 
the pre- and post-TS cleavage Mos1 PECs (Dornan et al., 2015, Richardson et al., 2009): each IR is 144 
recognised by the DNA-binding domain of one transposase subunit and by the catalytic domain of the 145 
other subunit (Figure 2b), and vice versa. This brings the cleaved transposon ends together, and ensures 146 
suitable spacing for their integration into TA target DNA.  Transposase interactions with IR DNA in the 147 
STC (Figure 2 – figure supplement 3) are similar to those in the post-TS cleavage PEC, suggesting that, 148 
after transposon excision, the transpososome is poised for target capture. Thus, rather than rearrange 149 
the transposase and IR DNA, target DNA is deformed to enable strand transfer.  150 
 151 
Mos1 transposase sharply bends target DNA  152 
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The target DNA is severely distorted from B-form conformation (Figure 2c): the backbone is bent by 147°, 153 
with the apex of the bend at the TA target dinucleotide. DNA unwinds most readily at TA sequences due 154 
to the inherent bendability of a pyrimidine-purine step (which has minimal base-to-base overlap and low 155 
twist angles) and the lower stability of a TA base pair, compared to CG. The strand transfer reaction 156 
creates a nick in both target DNA strands 5' of the target thymine T0, which likely relieves steric 157 
constraints and allows the extreme bend across the TA di-nucleotide. Transposase interactions with the 158 
backbone phosphates of target nucleotides surrounding the TA sequence support this conformation 159 
(Figure 2 – figure supplement 3). 160 
 161 
 162 
Strand transfer products are in proximity to the active sites 163 
The transposase performs three nucleophilic substitution reactions at each transposon end: sequential 164 
hydrolysis of both DNA strands to excise the transposon, followed by strand transfer to join the IR to 165 
target DNA (Figure 1a). One IR is transferred to the top strand (t, black, Figure 1b), and the other to the 166 
bottom strand (b, magenta, Figure 1b). In-line SN2 attack by each transposon 3'-OH on the scissile T0 167 
target DNA phosphate (Figure 1c) creates a new bond between the transposon end and the target 168 
thymine (T0). At the same time, the phosphodiester linking C-1 and T0 is broken, leaving a 3'-OH on C-1 and 169 
inverting the stereochemistry of the scissile T0 phosphate.   170 
 171 
Each Mos1 transposase active site comprises the carboxylate side-chains of three conserved aspartates 172 
(D156, D249 and D284) from the same catalytic domain, which coordinate the metal ions (Mg2+ or Mn2+) 173 
required for catalysis. One Mg2+ was observed in each active site in the Mos1 STC, coordinated by the 174 
D156 and D249 carboxylates, the 3'-OH of C-1 and a water molecule. The phosphodiester joining each 175 
transposon 3' end (A56) to a T0 passes close to an active site (Figure 2b,c,d). The T0 phosphate oxygens are 176 
4.4 Å and 7 Å from the Mg2+, precluding chelation. Moreover, the C-1 3'-OH is not in-line with the T0–A56 177 
phosphodiester bond, consistent with repositioning of the nascent transposon-target DNA junction, 178 
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away from the active site Mg2+ after strand transfer. Similar to the PFV STC (Maertens et al., 2010), this 179 
likely prevents self-destructive disintegration and drives transposition forwards.  180 
 181 
The target thymines are unpaired and flexible 182 
Each transposon–target thymine junction is clearly defined in the electron density map (Figure 2d). There 183 
is also clear density for the nucleobase of T0 on strand b (magenta) in active site B. However, we 184 
observed no clear density for the T0 base on strand t (active site A), indicating some disorder in its 185 
position. Therefore this nucleotide was built as abasic. In active site B the T0 nucleobase π−π stacks with 186 
the base of C-1 to which T0 would have been connected before strand transfer. The T0 base is unpaired 187 
and O4 is 3.4 Å from the H122 imidazole NH, suggesting a possible base-specific hydrogen bond (Figure 188 
3a). However, the mutation H122A had no effect on the strand transfer efficiency (Figure 3 – figure 189 
supplement 1), and we conclude that the putative thymine-specific hydrogen bond is not required for 190 
target integration and may be transient, due to T0 base mobility.  191 
 192 
The target adenines are flipped into extra-helical positions  193 
The most striking feature of the Mos1 STC structure is flipping of both target adenine (A1) bases of the 194 
symmetrical TA sequence into extra-helical positions (Figure 3a). The phosphate backbone atoms of A1 195 
and G2 are rotated by ~180°, with respect to the adjacent nucleotides, so that the A1 bases cannot pair 196 
with their complementary T0. Instead each unpaired A1 is wedged against the ribose face of the 197 
complementary target strand, at an oblique angle to bases G2 and C3 (Figure 3a).  The aromatic ring of 198 
each F187 occupies the space vacated by a flipped A1, forming a π−π stack with the adjacent G2 199 
nucleobase, stabilising this conformation (Figure 3a).  200 
 201 
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To confirm A1 flipping in solution, and to investigate the extent and dynamics of this distortion, we 202 
performed fluorescence experiments with DNA containing the adenine analogue 2-aminopurine (2AP). 203 
2AP is an exquisitely sensitive probe of chemical environment: its fluorescence is highly quenched by 204 
stacking with the DNA bases and, hence, is sensitive to local duplex structure and enzyme-induced 205 
distortion of that structure (Jones and Neely, 2015).  206 
 207 
We designed three DNA duplexes, each mimicking the strand transfer product: TA1, an unlabelled 208 
control analogous to the oligonucleotide used for STC crystallisation (Figure 3b); TP13, a labelled control, 209 
with 2AP in place of A13 on the top target strand (black, Figure 3c), where it is base-paired and stacked in 210 
duplex DNA; TP1, with 2AP in place of A1 (Figure 3d), where the unpaired 2AP is stacked with the 211 
adjacent T0 and G2 bases. Upon addition of Mos1 transposase to TA1, we observed complete formation 212 
of a nucleoprotein complex by gel-filtration chromatography (Figure 3b).  When Mos1 transposase was 213 
added to TP13, there was no measurable change in the (very low) steady-state fluorescence intensity at 214 
367 nm (inset, Figure 3c), consistent with no change in the 2AP environment upon STC formation. In 215 
contrast, there was a 10-fold increase in fluorescence intensity when Mos1 transposase was added to 216 
TP1 (inset, Figure 3d), consistent with 2AP at the target site becoming unstacked by flipping into an 217 
unquenched, extra-helical environment in the Mos1 STC.   218 
 219 
A dynamic picture of DNA conformations in solution can be gained from the interpretation of the 220 
fluorescence decay of 2AP, measured by time-resolved fluorescence spectroscopy.  In duplex DNA the 221 
exponential decay of 2AP fluorescence is typically described by four lifetime components, each reporting 222 
on different quenching environments that 2AP experiences as a result of the conformational dynamics of 223 
the duplex. The lifetime indicates the degree of quenching (stacking) in a particular conformation and 224 
the corresponding A–factor indicates the fractional occupancy of that conformation. The shortest 225 
lifetime (τ1 ≅ 50 ps) is due to a highly stacked conformation, which typically accounts for >70% of the 226 
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population. The longest lifetime (τ4 ≅ 9-10 ns) corresponds to an unstacked conformation in which 2AP is 227 
extra-helical and solvent-exposed; this conformation is typically <5% of the population. The intermediate 228 
lifetimes (τ2 ≅ 500 ps and τ3 ≅ 2 ns) are due to conformations in which 2AP is intra-helical but imperfectly 229 
or partially stacked. 230 
 231 
 232 
We measured the fluorescence decays of the 2AP-containing DNA duplexes TP13 and TP1 in the absence 233 
and presence of Mos1 transposase (Figure 3c,d). In the absence of transposase, 90% of the 2AP 234 
population of TP13 has the shortest lifetime (τ1=30ps), indicating a tightly stacked duplex structure.  235 
Upon addition of Mos1 transposase, the decay parameters are essentially unchanged showing that the 236 
local duplex structure is unaffected, confirming the steady-state fluorescence results. TP1 fluorescence 237 
decay, in the absence of protein, is also dominated by the shortest lifetime, stacked component (76%, 238 
τ1 = 50 ps, Figure 3d), with only 6% of the population in the unstacked state (τ4 = 7.5 ns). (The differences 239 
in the decay parameters between TP13 and TP1 are consistent with a less tightly stacked environment in 240 
the latter, where 2AP is unpaired). However, upon addition of transposase to TP1, the decay parameters 241 
change markedly (Figure 3d). Most notably, there is a large transfer of population from the highly 242 
stacked state (τ1 = 80 ps) to the unstacked, unquenched state (τ4 = 9.7 ns); the population of the former 243 
falls to 38% and that of the latter increases concomitantly to 31%. This clearly confirms that, in solution, 244 
2AP at the position of the target adenine A1 in the Mos1 STC experiences base-flipping into an extra-245 
helical environment. Moreover, flipping of this 2AP is dynamic: a number of conformational states are 246 
sampled, including base-flipped and base-stacked environments.  247 
 248 
 249 
Transposase residues stabilise the distorted target DNA backbone 250 
Base flipping of each A1 severely distorts the surrounding target DNA. Side-chain atoms of transposase 251 
residues R186, K190 and W159 stabilise these distortions (Figure 4a) by forming salt bridges or hydrogen 252 
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bonds with the A1 and G2 phosphates. The DNA backbone rotations bring the G2 phosphates on both 253 
target DNA strands within 6.7 Å of each other and close to the guanidinium group of R186 in subunit A 254 
(R186A); each NηH2 group hydrogen bonds with a G2 phosphate oxygen on one strand (Figure 4a).  In 255 
both subunits, the K190 side-chain NζH2 forms a salt bridge with the other G2 phosphate oxygen on one 256 
strand.  Furthermore, the W159 indole N1H interacts with an A1 phosphate oxygen. Additionally, the 257 
NηH2 group of R186B (which has a different conformation to R186A) interacts with the other A1 258 
phosphate oxygen on the top strand (black, Figure 4a). The NζH2 of K190 is 5.2 Å from the W159 indole 259 
ring and forms a cation-π stack, further enhancing stability.  Together these extensive transposase–DNA 260 
backbone phosphate interactions stabilise the distorted conformation of the strand transfer product.  261 
 262 
Residues that stabilise the transposition product are required for strand transfer in vitro 263 
Consistent with the structural roles of W159, R186, F187 and K190 in the STC, individual substitution of 264 
each of these residues with alanine severely reduced the in vitro strand transfer activity of transposase 265 
(Figure 4b). We detected <0.03%  integration of fluorescently labelled Mos1 IR DNA into a target DNA 266 
duplex with a sole TA, using transposases containing the mutation W159A, R186A, K190A or F187A 267 
(Figure 4c,d). By contrast, the F187W substitution resulted in 9.5 % strand transfer, compared to 9.1 % 268 
with T216A Mos1 transposase. Thus, an indole ring, like a phenyl ring, can occupy the space vacated by 269 
the flipped A1 base and stabilise the strand transfer product by stacking with the G2 base.  The individual 270 
substitutions W159A, K190A or F187A also reduced the in vitro transposition efficiency to <20% that of 271 
T216A Mos1 transposase (Figure 5).  272 
 273 
To test if W159, R186, F187 and K190 are also required for transposon excision, we performed a plasmid-274 
based transposon cleavage assay (Figure 6a). Transposon excision, and concomitant plasmid backbone 275 
release, was not affected by the transposase mutations R186A, F187A, F187W, K190A, F161A or F161W 276 
(Figure 6b,c). However, the W159A mutant transposase excised only 3.9 % of the plasmid after 24 hours, 277 
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compared to 55.6% for the T216A transposase. Thus, Mos1 transposase residues F187, R186 and K190 278 
are required for target DNA integration, but are not essential for earlier cleavage steps, whereas W159 is 279 
required for both excision and strand transfer. 280 
    281 
Target DNA stabilising amino acids are conserved in mariner transposases 282 
Alignment of the Mos1 transposase sequence , with other mariner and Tc1-like transposases (Figure 7), 283 
reveals that K190 and W159, which form a cation-π stack and interact with target DNA phosphates, are 284 
strictly conserved among mariner transposases. Despite the crucial role of Mos1 R186 for strand transfer 285 
in vitro, this residue is not conserved in all mariner transposases.  However, the aromatic nature of F187 286 
is conserved as either F or H in most other mariner transposases. Thus, many of the target-stabilising 287 
interactions observed in the Mos1 STC may also exist in other mariner transposases.  288 
 289 
The Tc1-like sequences have a conserved lysine at the position equivalent to W159 in Mos1 and there 290 
are two, proximal conserved tryptophans – aligned with Mos1 residues 149 and 194 – which could fulfil 291 
the role of W159 in Mos1 (Figure 7). Furthermore, the Tc1-like transposases contain either K or R one 292 
amino acid upstream of R186 in Mos1, followed by an aromatic residue: F, H or Y.  These residue pairs 293 
could stabilise target DNA in a similar way to R186 and F187 in Mos1. Thus, there may be common 294 
features in the target DNA integration mechanisms of the two branches of the mariner/Tc1 family. 295 
 296 
Transposase recognises the flipped target adenines via base-specific interactions  297 
The target-stabilising interactions described above are non-specific. In contrast, in the flipped 298 
conformation, the Watson-Crick face of each unpaired A1 base makes two adenine-specific hydrogen 299 
bonds with V214 backbone atoms (Figure 8a):  the exocyclic 6-amine interacts with the carbonyl oxygen, 300 
and N1 interacts with the backbone amide.  301 
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 302 
To test if these adenine-specific hydrogen bonds are important for transposon integration specifically at 303 
a TA, we performed in vitro strand transfer assays with 2AP-containing target DNA.  The arrangement of 304 
H-bond donors differs between adenine and 2AP (Figure 8b). Therefore, by replacing each A1 with 2AP 305 
we expect to lose the H-bond between the A1 6-amino and V214 CO, and introduce a steric clash 306 
between the 2-amino of 2AP and T213 Cα. Since 2AP, like adenine, can make two hydrogen bonds in a 307 
base pair with thymine (Figure 8b), replacing A1 with 2AP is unlikely to alter the stability and bendability 308 
of duplex target DNA. 309 
 310 
We found that replacing both A1s with 2AP (Figure 8c,d) resulted in a dramatic loss of specific integration 311 
at each T0 5' of the 2AP, consistent with the predicted loss of adenine-specific hydrogen-bonds with 312 
transposase.  Our fluorescence experiments show that 2AP at position 1 in target DNA undergoes 313 
dynamic base flipping in the Mos1 STC (Figure 3d), whereas our crystallographic snapshot with adenine 314 
at the equivalent position suggests a static flipped conformation. This may reflect different experimental 315 
conditions: the fluorescence experiments were performed in solution at room temperature, whereas the 316 
crystal structure was obtained at cryogenic temperatures. However, it is also consistent with a lack of 317 
specific interactions between 2AP and transposase, leading to an inability to trap the flipped 2AP 318 
conformation. We conclude that Mos1 integration at TA requires adenine-specific interactions with 319 
transposase to trap the flipped A1 conformation.  320 
 321 
Next we asked which A1 of the symmetrical TA sequence is essential for integration at T0: the adjacent A1 322 
on the same strand or the complementary A1. We replaced each A1 individually with 2AP, and efficient 323 
Mos1 integration occurred at a T0–A1 step when the T0 was base-paired with 2AP, but was reduced at a 324 
T0–2AP1 step (Figure 8c,d). We conclude that specific Mos1 integration at a T0 requires trapping of the 325 
flipped A1 adjacent to it on the same strand.  326 
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 327 
Finally we asked if the lower stability of a T:A base-pair, compared to G:C, favours mariner/Tc1 328 
transposon integration at TA sites. We predicted that A1 flipping, and therefore strand transfer, would be 329 
hindered if the T:A base-pairing was strengthened by a third hydrogen bond, but enhanced with 330 
weakened base pairs. We replaced both A1s with 2,6-diaminopurine (2-amino-dA, or D), which forms 331 
three hydrogen bonds with dT (thereby increasing base-pair stability) but only one hydrogen bond when 332 
paired with 2-thio-dT (or S) (Kutyavin et al., 1996)(Figure 8b). 2-amino-dA can form the adenine-specific 333 
interactions with V214 seen in the Mos1 STC structure, however the 2-amino group adds a potential 334 
clash with transposase that could lead to reduced specificity.   335 
 336 
We compared Mos1 strand transfer into TA and the altered target sequences TD and SD, with 337 
strengthened and weakened base pairing respectively (Figure 8c, lanes 10 and 11). We measured 6.99% 338 
integration into TA, but only 0.24% integration into the TD sequence  (Figure 8c,d) and 0.86% integration 339 
into SD (Figure 8c); in the latter experiment many other, non-specific integration products were also 340 
observed. Thus, the weakness of the T:A base pair promotes integration at the TA sequence, and the 341 
pattern of H-bond donors and acceptors on the Watson-Crick face of adenine is important for specificity. 342 
 343 
Discussion 344 
The Mos1 STC structure provides a snapshot of Mos1 transposition in the post-integration state. The 345 
severe target DNA bend (~147°) is consistent with a bias for mariner/Tc1 integration at highly bendable, 346 
palindromic AT-rich sequences (Vigdal et al., 2002, Yant et al., 2005). Studies by Pflieger et al. suggested 347 
that target DNA also bends before Mos1 strand transfer (Pflieger et al., 2014). Comparison of the Mos1 348 
STC structure with our previous TCC model (containing straight target DNA) and both the pre- and post-349 
TS cleavage PECs (Dornan et al., 2015, Richardson et al., 2009) supports this conclusion. Our previous TCC 350 
model (Richardson et al., 2009) of straight B-form target DNA binding highlighted clashes with some 351 
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transposase loop residues, indicating conformational changes in the target DNA and/or the transposase 352 
would be required for target capture.  The similar architectures and interactions of the IR DNA and 353 
transposase in the STC and both PEC structures (Figure 9a and Figure 9 – figure supplement 1) suggest 354 
that target DNA is likely deformed. Changes to the transposase conformation are subtle and include 355 
closing-in of the catalytic domain towards the target DNA after strand transfer (Videos 1 and 2). The 356 
largest displacement (5.7 Å) is at P210 in the turn between β7 and α8 and around helices α8 and α10, 357 
which cradle the target DNA (Figure 9b).  T0 in the Mos1 STC is in a different orientation to the thymine 358 
(T57) of the flanking target site duplication in the pre-TS cleavage PEC (Figure 9c), which is recognised by 359 
base-specific interactions with the WVPHEL motif (Dornan et al., 2015). By contrast, T0 closely aligns with 360 
T54 of the additional DNA duplex in the post-TS cleavage PEC (Figure 9d), which may represent the target 361 
strand before integration.  362 
 363 
Strain created by target DNA bending during target capture likely drives the phosphate backbone 364 
rotations that flip the target adenines into extra helical positions (Figure 10). Subsequent trapping of the 365 
flipped adenines may correctly position the scissile target phosphates for in-line attack by the cleaved 366 
transposon ends. Breaking of the target DNA strands by strand transfer would allow displacement of the 367 
new transposon-target DNA junction from the active site, preventing reversal of the reaction. Structural 368 
and biochemical characterisation of the target capture complex will illuminate this sequence of events. 369 
 370 
Many DNA-metabolising enzymes use base flipping to expose bases normally embedded within a double 371 
helix; enabling base methylation (Klimasauskas et al., 1994), removal of damaged or mismatched bases 372 
or for DNA sequence recognition (Bochtler et al., 2006, Neely et al., 2009). During Tn5 transposon 373 
excision, formation and resolution of DNA hairpins at the transposon ends requires base flipping: 374 
rotation of a base close to the cleavage site, into a protein pocket, relieves strain in the tight hairpin 375 
bend and aligns the transposon ends for cleavage (Ason and Reznikoff, 2002). Similarly, DNA hairpin 376 
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stabilisation by base flipping has been proposed for V(D)J recombination and transposition of Hermes 377 
and Tn10 (Lu et al., 2006, Bischerour and Chalmers, 2009).  378 
 379 
Active intrusion of a probe amino acid residue can drive base flipping. During Mos1 integration, the F187 380 
aromatic ring may actively force the A1s from the DNA helix, similar to the methionine probe in Tn10 381 
transposon excision (Bischerour and Chalmers, 2009). Alternatively, F187 may passively fill the gap left 382 
by A1 after flipping, to enhance the stability of the distorted target DNA conformation.  In this scenario, 383 
the conserved transposase residues K190 and W159 may be alternative drivers of the base-flipping 384 
rotations. 385 
 386 
Target adenine–specific interactions with V214 backbone atoms suggest a molecular basis for TA target 387 
sequence recognition in the post-integration state. The structured loop containing V214 has the 388 
consensus sequence T-(V/I)-(N/T) in mariner transposases (Figure 7), suggesting that the role of 389 
transposase backbone atoms in TA recognition may be conserved among mariner-family transposases. 390 
The Tc1-family transposases, including Sleeping Beauty, also display sequence conservation in this region 391 
(Figure 7), suggesting similar recognition mechanisms exist in that closely-related family. Structures of 392 
Sleeping Beauty transposition intermediates will reveal if this is the case. 393 
 394 
Target DNA bending is a recurring theme in DNA transposition by DDE/D recombinases. The severe 395 
target DNA bend (~147°) observed in our Mos1 STC structure is similar to the ~140° target DNA distortion 396 
in the bacterial MuA transpososome, which was proposed to drive the isoenergetic strand transfer 397 
reaction forward (Montano et al., 2012). Mu employs a helper protein (MuB) in its transposition, which 398 
may facilitate target DNA bending by forming helical filaments on DNA, prior to capture by the MuA 399 
transpososome (Mizuno et al., 2013). Similarly, the bacterial insertion sequence IS21 requires IstB for 400 
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efficient transposition.  In the presence of ATP, IstB self-assembles into decamers that can bend ~50 bp 401 
DNA by 180° (Arias-Palomo and Berger, 2015). In the PFV integrase target capture and strand transfer 402 
complexes (Maertens et al., 2010) naked target DNA is bent by 55°. Nucleosomal DNA is peeled from the 403 
histone octamer and similarly deformed by interactions with the PFV intasome, providing a structural 404 
basis for retroviral integration at nucleosomes (Maskell et al., 2015).  By contrast, recent evidence 405 
indicates that mariner/Tc1 transposons preferentially integrate at linker regions between nucleosomes 406 
(Gogol-Doring et al., 2016). Our results provide a structural basis for this preference: severe target DNA 407 
bending (~147°) by the transpososome can be more easily achieved on flexible linker DNA than on DNA 408 
tightly engaged with the histone octamer in a nucleosome structure.  409 
 410 
Taken together our structural and biochemical data support a dynamic bend, flip and trap mechanism for 411 
Mos1 transposon integration at TA target sites (Figure 10) that may be a conserved feature of 412 
mariner/Tc1 transposition. As such, our results provide a framework for designing mariner/Tc1 413 
transposases with modified target specificities.   414 
 415 
Materials and methods 416 
Transposase mutation, expression and purification 417 
Expression constructs encoding Mos1 transposase mutants H122A, W159A, F161A, F161W, R186A, 418 
F187A, F187W, K190A were generated by site-directed mutagenesis (Quikchange, Stratagene) of the 419 
codon-optimised Mos1 gene (Trubitsyna et al., 2014), according to the manufacturer’s protocol. Each 420 
plasmid also incorporated the T216A mutation allowing soluble expression of Mos1 transposase in E. coli 421 
(Richardson et al., 2004).   Each mutant transposase was expressed and purified as described previously 422 
(Richardson et al., 2004), exchanged into buffer containing 25 mM PIPES pH 7.5, 250 mM NaCl, 0.5 mM 423 
DTT and 50% (v/v) glycerol and concentrated to between 10-20 mg mL-1. 424 
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 425 
Preparation of ds DNA substrates 426 
The sequences of all DNA oligonucleotides are shown in Table 1. HPLC purified oligonucleotides for 427 
crystallisation of the STC were purchased from IDT (Belgium), PAGE purified and dissolved to 1 mM in 428 
TEN buffer (10mM Tris pH 8, 1 mM EDTA, 50 mM NaCl). The 36 nt TS incorporates the 28 nt IR and target 429 
DNA (as shown in Figure 1c). The 25 nt NTS is complementary to the TS IR DNA sequence and represents 430 
the authentic product the first cleavage. The 10 nt target DNA sequence, includes six nucleotides 431 
complementary to the 3' TS target sequence and four self-complementary nucleotides (cohesive 5' 432 
ends).  The three oligonucleotides were mixed in a 1:1:1 molar ratio and annealed by heating to 363 K for 433 
3 minutes and cooling to room temperature over ~2 hours.  434 
 435 
For time-resolved fluorescence experiments, DNA oligonucleotides were synthesised and HPLC purified 436 
by ATDBio (Southampton, UK). Three TS sequences, extended at the 3' end to 46 nt, were synthesised: 437 
TS_A1, an unlabelled control; TS_P1, with 2AP in place of the target adenine; TS_P13 with 2AP at 438 
position 13, another control. Each TS was annealed with the 25 nt NTS and the 16 nt target_16 sequence 439 
complementary to the TS 3' end.  This yielded the three duplexes – TA1, TP1 and TP13 – which mimic the 440 
Mos1 strand transfer product.  441 
 442 
For the strand transfer assays, the IR DNA was prepared by annealing the 28 nt 5'-IRDye® 700 labelled  TS 443 
with the 25 nt complementary NTS.  The 50-mer TA target DNA, was prepared by annealing 444 
complementary top and bottom strands (Table 1). Five target DNA variants were similarly prepared: 445 
three had 2-aminopurine (P) in place of the target adenine on the top and/or bottom strand.  A fourth 446 
had 2,6-diaminopurine (D) in place of the target adenine on both strands, and the fifth also had 2-thio-447 
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thymine (S) in place of the target thymine on both strands. The annealed IR and target oligonucleotides 448 
were purified by HPLC.  449 
 450 
Preparation of the Mos1 STC 451 
The STC was formed by adding T216A Mos1 transposase (438 μM) and STC ds DNA (229 μM) together to 452 
final concentrations of 50 μM each in a solution of 25 mM PIPES-NaOH pH 7.5, 250 mM NaCl, 20 mM 453 
MgCl2 and 1 mM DTT. The final concentration of the STC was 25 μM. 454 
 455 
Crystallisation 456 
Crystals were grown by sitting drop vapour-diffusion. Drops contained 2 μL of STC (25 μM) and 1 μL of 457 
well solution comprising 30% (v/v) MPD, 0.1 M sodium cacodylate pH 6.5 and 0.2 M magnesium acetate 458 
tetrahydrate. The crystals were cooled in liquid nitrogen for X-ray diffraction experiments.  459 
 460 
X-ray crystal structure determination and refinement.  461 
X-ray diffraction data were collected on beam line I02 at the Diamond Light Source. Crystals displayed C-462 
centred (C121) symmetry and diffracted X-rays to a maximum resolution of 3.3 Å. The X-ray diffraction 463 
data were processed with iMosflm, scaled and merged with AIMLESS and the statistics are shown in 464 
Table 2. Initial phases were determined by molecular replacement, using our structure of the Mos1 PEC 465 
(PDB ID: 3HOS, chains A to F, comprising the transposase dimer and two cleaved IR DNA molecules) as 466 
the search model in PHASER. The difference electron density after molecular replacement is shown in 467 
Figure 2–figure supplement 1. The remaining structure was built manually. Restrained refinement was 468 
performed with Refmac and Coot and included automatic non-crystallographic symmetry restraints on 469 
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the protein and DNA chains. The refinement statistics are shown in Table 2. All structural diagrams were 470 
prepared using PyMOL (http://www.pymol.org/) and Adobe Illustrator.  471 
 472 
In vitro strand transfer and transposon cleavage assays. 473 
Target integration assays were performed as described previously (Wolkowicz et al., 2014). 20 μL 474 
reactions containing 15 nM of a 50-mer target DNA, 1.5 nM IR DNA and 15 nM Mos1 transposase in 475 
buffer containing 25 mM HEPES pH 7.5, 50 mM Potassium Acetate, 10 % (v/v) glycerol, 0.25 mM EDTA, 476 
1mM DTT, 10 mM MgCl2, 50 μg/mL BSA and 20 % (v/v) DMSO were incubated for two hours at 30°C and 477 
the products separated on an 8 % denaturing polyacrylamide gel. To visualise the products, the 478 
IRDye®700 was excited at 680 nm and detected on a LI-COR Odyssey system. The fluorescence intensities 479 
of the product bands were quantified using Image Studio software. Plasmid-based transposon cleavage 480 
assays were performed as described previously (Trubitsyna et al., 2014).  481 
 482 
Steady state fluorescence  483 
Measurements were acquired, in photon counting mode, on a Fluoromax–3 spectrofluorimeter (Jobin 484 
Yvon, Stanmore, UK), on samples of the 2AP-containing duplexes TP13 or TP1 (10 μM), alone or mixed 485 
with 11 μM Mos1 transposase, in buffer composed of 25 mM PIPES-NaOH pH 7.5, 250 mM NaCl, 20 mM 486 
CaCl2, 1 mM DTT. A circulating water bath maintained sample temperatures at 25°C. Emission spectra 487 
were recorded in the range 325–550 nm, with an excitation wavelength of 317 nm and excitation and 488 
emission bandwidths of 2.5 nm.  489 
 490 
Time-resolved fluorescence   491 
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Measurements were performed using time-correlated single photon counting, on an Edinburgh 492 
Instruments spectrometer equipped with TCC900 photon counting electronics, as described previously 493 
(Neely et al., 2005). The excitation source was the third harmonic of the pulse-picked output of a Ti-494 
sapphire femtosecond laser system (Coherent, 10 W Verdi and Mira Ti-Sapphire), consisting of ~200 fs 495 
pulses at a repetition rate of 4.75 MHz and a wavelength of 317 nm. The instrument response of the 496 
system was ~80 ps full-width at half-maximum.   497 
 498 
Fluorescence decay curves were analysed by iterative re-convolution, assuming a multi-exponential 499 
decay function, given in Equation (1) 500 
ܫሺݐሻ =  ∑ ܣ௜݁ݔ݌ ቀି௧ఛ೔ ቁ
ସ௜ୀଵ    (1) 501 
where I is the fluorescence intensity as a function of time (t); τi is the fluorescence lifetime of the ith 502 
decay component and Ai is the fractional amplitude (A-factor) of that component. 503 
Decays were collected at two emission wavelengths (375 nm and 390 nm) and were analysed globally, 504 
with τi as the common parameter, using Edinburgh Instruments software FAST.  505 
 506 
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Figures  648 
 649 
Figure 1. Mos1 transposition. (a) Schematic of pathway and complexes formed. Each transposon end has 650 
a 28 bp IR sequence (triangle) flanked by the TA target site duplication. First and second strand cleavages 651 
(scissors) are staggered by three bp and generate a 5' phosphate (filled circle) on the non-transferred 652 
strand (NTS), 3 bases within the IR, and a 3'OH (arrow) at the transferred strand (TS) end, respectively. 653 
After target DNA capture, the transposon 3' ends integrate at a symmetrical TA sequence, resulting in a 5 654 
nt gap. Gap repair duplicates the TA. (b) Mos1 strand transfer. The transposon 3'OHs attack the 655 
phosphodiester bond between T0 and C-1 on both the top (t, black) and bottom (b, magenta) target DNA 656 
strands, joining each TS to target DNA, separating the TA base pairs, and leaving a 3'OH at C-1. (c) 657 
Sequence and numbering of the DNA used to crystallise the STC; see also Table 1. 658 
 659 
Figure 2. Architecture of the Mos1 strand transfer complex.  (a) Structure of the STC, with transposase 660 
subunits (orange and blue), IR DNA (orange and green) and target DNA (magenta and black). Figure 2–661 
figure supplement 1 shows the crystal packing arrangement. (b) Schematic of the Mos1 STC. See Figure 662 
2–figure supplement 2 for details of transposase DNA interactions. (c) DNA components of the STC: 663 
target DNA is bent and each IR TS connects at the 3' end to a target DNA strand. (d) The active site of 664 
catalytic domain B, showing the product of strand transfer into the bottom target strand (magenta). The 665 
simulated annealing composite omit 2Fo-Fc electron density map (grey mesh) is contoured at 1.2σ. The 666 
single Mg2+ is coordinated by D249, D156 and the 3'OH of C-1. 667 
 668 
Figure 3. Dynamic base flipping of the target adenines. (a) Target DNA binding in the Mos1 STC, showing 669 
the flipped A1 conformation.  The unpaired T0 base stacks with the C-1 base of the same strand. See 670 
Figure 3– figure supplement 1 for the effect on strand transfer activity of the mutation H122A. (b) 671 
Schematic of the TA1 DNA duplex and gel filtration chromatograms of Mos1 transposase (red), TA1 672 
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(blue) and the STC (black). UV absorbance at 280 nm (solid line) and 260 nm (dotted line).  (c and d) 673 
Fluorescence spectroscopy of the 2AP-labelled DNA oligonucleotides TP13 and TP1, shown schematically 674 
in (c) and (d) respectively. The A-factor (fractional population) and lifetime of each of the four 675 
fluorescence decay components are plotted for TP13 and TP1 alone (black circles and lines) and in the 676 
presence of Mos1 transposase (red triangles and lines); and tabulated in Figure 3–source data 1. The 677 
steady-state fluorescence emission spectra are inset in each case. 678 
 679 
Figure 4. Transposase interactions with rotated backbone phosphates stabilise the target DNA. (a) 680 
Target DNA phosphate interactions with catalytic domain residues. The side-chains of R186, W159 and 681 
K190 can form hydrogen bonds (dotted lines) with backbone phosphate oxygens of A1 and G2 (distances 682 
in Å). (b) Schematic of the in vitro Mos1 strand transfer assay. Integration of the 28 nt TS into the top 683 
target strand, yields a 68 nt product, whereas integration into the bottom strand gives a 40 nt product.  684 
(c) Denaturing PAGE of the strand transfer reaction products. Lanes 1 and 12 contain markers; lanes 2 685 
and 13, reactions without transposase; lanes 3 and 14, reactions without target DNA. (Integration occurs 686 
at the two TA dinucleotides in the IR sequence).  (d) Quantification of the 40 nt and 68 nt products (as a 687 
percentage of total DNA) for each mutant transposase; error bars represent the standard deviation and 688 
were calculated from 3 experiments.   689 
 690 
Figure 5. Residues that stabilise the transposition product are required for efficient Mos1 transposition 691 
in vitro. Efficiencies of an in vitro Mos1 hop assay, performed using Mos1 transposase mutants and 692 
donor plasmids containing a kanamycin resistance gene flanked by Mos1 inverted repeats, as described 693 
previously (Trubitsyna et al., 2014). Excision of the IR-flanked gene from a circular plasmid by 694 
transposase, and its integration into a supercoiled target plasmid, results in transfer of the kanamycin 695 
resistance to the target plasmid. Each mutant transposase also contained the mutation T216A, which 696 
allows soluble protein expression. Sequencing of the transposition products revealed that each mutant 697 
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transposases retained faithful integration at TA sites.  Error bars represent the standard deviation, 698 
calculated from three repeats of two experiments.  699 
 700 
Figure 6.  Plasmid-based transposon cleavage assays. (a) Schematic of the in vitro plasmid-based Mos1 701 
cleavage assay. (b) Agarose gel showing the products of plasmid-based transposon cleavage assays, for 702 
each mutant transposase (Tnp) after 2 hrs and 24 hrs. Control experiments show linearization of the 703 
plasmid with Sac1 (lane 2), excision of the transposon by Xba1 digestion (lane 3) and reaction with no 704 
transposase (lane 4).  (c) Quantification of the transposon and plasmid backbone released (as a 705 
percentage of total DNA) after 2 hrs and 24 hrs. Error bars represent the standard deviation calculated 706 
from 2 experiments.  707 
 708 
Figure 7. Alignment of the amino acid sequence of Mos1 with six other mariner transposases and five 709 
Tc1-family transposases.  The secondary structure elements of Mos1 transposase in the Mos1 STC are 710 
shown above the alignment. A red star below the alignment denotes the position of each of the catalytic 711 
acidic residues of the DDE/D triad. The third residue of this triad is typically D in the mariner sub-family 712 
and E in the Tc sub-family. The key residues involved in target DNA stabilisation in the Mos1 STC are 713 
highlighted in blue and marked by a blue dot. The figure was created with ESPript 3.0 714 
(http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi). 715 
 716 
Figure 8. Base-specific recognition of the flipped adenine. (a) Close up view of one of the flipped target 717 
adenines in the Mos1 STC crystal structure showing the hydrogen bond interactions (dotted cyan lines, 718 
distance in Å) with the V214 backbone atoms and the 2 and 6 positions of the adenine ring. The 719 
simulated annealing composite omit 2Fo-Fc electron density map (grey mesh) is contoured at 1.2σ. (b) 720 
Chemical structures and base-pairing of adenine, A, and its analogues 2-aminopurine, P, and 2,6-721 
diaminopurine, D, with thymine, T or 2-thio-thymine, S. A steric clash between the 2-thio group of S and 722 
the 2-amino group of D tilts the bases relative to each other, and thus only one H-bond forms. (c) 723 
29 
 
Denaturing PAGE of the products of strand transfer reactions with target DNA containing adenine and/or 724 
thymine analogues, as indicated above lanes 4 to 11. (d) Quantification of the 40 nt and 68 nt strand 725 
transfer products for each target DNA duplex, as a percentage of total DNA. Error bars represent the 726 
standard deviation, calculated from 2 experiments.   727 
 728 
Figure 9. Structural comparison of the Mos1 STC with the pre- and post-TS cleavage Mos1 paired-end 729 
complexes.  (a) Orthogonal views of the Mos1 STC (orange) superimposed on the pre-TS cleavage PEC 730 
(PDB ID: 4U7B, green): r.m.s.d. over all transposase backbone atoms, 1.2 Å. Video 1 and video 2 show the 731 
transposase morphing from the pre- and post-cleavage PEC structures to the STC, respectively. (b) Close-732 
up view of part of the catalytic domain, boxed in (a). Mos1 STC target DNA and the pre-TS cleavage PEC 733 
flanking DNA are shown as sticks (pink and black) and a green cartoon, respectively.  Dotted lines 734 
indicate the displacement between the two structures, with distances in Å. (c) and (d) Close-up view of 735 
the Mos1 STC (orange) active site superimposed on (c) the pre-TS cleavage PEC (green) and (d) the post-736 
TS cleavage PEC (PDB ID: 3HOS): T54 in the additional DNA duplex (lavender sticks) may represent T0 of 737 
target DNA before strand transfer. A full view of the Mos1 STC superposed on the post-TS cleavage PEC 738 
structures is shown in Figure 9 – figure supplement 1.  739 
 740 
Figure 10. A proposed mechanism for Mos1 transposon integration incorporates target DNA bending 741 
and trapping of flipped target adenines. Schematic representation of key features of the STC (right) and 742 
the proposed target capture complex (left), with transposase subunits (orange and blue). Filled circles 743 
represent residues W159 (W), R186 (R), F187 (F) and K190 (K) and the encircled DDD depicts each active 744 
site. Arrows indicate rotation of the DNA backbone of each target DNA strand (magenta and black).  745 
Dotted lines represent hydrogen bonds between TA base pairs in the TCC and between flipped target 746 
adenines and transposase backbone atoms in the STC.   747 
  748 
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Tables 749 
Table 1. Sequences of oligonucleotides used in the crystallisation, target integration and fluorescence 750 
experiments. The target TA dinucleotide (and its variants) are highlighted in bold. The adenine analogue 751 
2-aminopurine is denoted P and 2,6-diaminopurine is D; the thymine analogue 2-thio-thymine, is 752 
indicated by S. IR700 indicates the 5' addition of the infrared fluorescent dye 700.  753 
Name Sequence  Length (nt) 
Crystallisation of STC 
TS 5' AAA CGA CAT TTC ATA CTT GTA CAC CTG ATA GCA GTG 36  
NTS  5' GGT GTA CAA GTA TGA AAT GTC GTT T 25  
target DNA  5' GGC CCA CTG C 10  
Target Integration Assays 
TS IR DNA  5' AAA CGA CAT TTC ATA CTT GTA CAC CTG A 28  
TS 5' labelled IR DNA 5' IR700 / AAA CGA CAT TTC ATA CTT GTA CAC CTG A 28 
NTS IR DNA 5' GGT GTA CAA GTA TGA AAT GTC GTT T 25  
TA target DNA  
(top strand) 
5' AGC AGT GCA CTA GTG CAC GAC CGT TCA AAG CTT CGG 
AAC GGG ACA CTG TT 
50 
TA target DNA 
(bottom strand) 
5' AAC AGT GTC CCG TTC CGA AGC TTT GAA CGG TCG TGC 
ACT AGT GCA CTG CT 
50  
TP target DNA  
(top strand) 
5' AGC AGT GCA CTP GTG CAC GAC CGT TCA AAG CTT CGG 
AAC GGG ACA CTG TT 
50 
TP target DNA 
(bottom strand) 
5' AAC AGT GTC CCG TTC CGA AGC TTT GAA CGG TCG TGC 
ACT PGT GCA CTG CT 
50 
TD target DNA  
(top strand) 
5' AGC AGT GCA CTD GTG CAC GAC CGT TCA AAG CTT CGG 
AAC GGG ACA CTG TT 
50 
TD target DNA 
(bottom strand) 
5' AAC AGT GTC CCG TTC CGA AGC TTT GAA CGG TCG TGC 
ACT DGT GCA CTG CT 
50 
SD target DNA 
 (top strand) 
5' AGC AGT GCA CSD GTG CAC GAC CGT TCA AAG CTT CGG 
AAC GGG ACA CTG TT 
50 
SD target DNA 
(bottom strand) 
5' AAC AGT GTC CCG TTC CGA AGC TTT GAA CGG TCG TGC 
ACS DGT GCA CTG CT 
50 
Fluorescence experiments 
TS_P1  5' AAA CGA CAT TTC ATA CTT GTA CAC CTG AtP gca gtg gac 
gta ggc c 
46 
TS_P13 5' AAA CGA CAT TTC ATA CTT GTA CAC CTG Ata gca gtg gac 
gtP ggc c 
46 
TS_A1 5' AAA CGA CAT TTC ATA CTT GTA CAC CTG Ata gca gtg gac 
gta ggc c 
46 
NTS 5' GGT GTA CAA GTA TGA AAT GTC GTT T 25  
Target_16 5' g gcc tac gtc cac tgc 16 
  754 
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Table 2.  X-ray diffraction and refinement statistics 755 
Crystal  Mos1 Strand transfer complex
PDB ID 5HOO 
Space group C121 
Cell dimensions  a = 256.3 Å  b = 58.9 Å  c = 110.2 Å 
α = 90.0 °,  β = 94.9 °, γ = 90.0 ° 
Wavelength (Å) 0.9795
Average mosaicity 0.22 
 Overall Outer shell
Resolution  (Å) 86.99-3.29 3.52-3.29 
Rsymm 0.077 0.152 
Total observations 78358 14630 
Unique observations 25201 4479 
< I>/σ<I>  8.1 3.3 
Correlation CC 0.927 0.996 
Completeness (%) 99.6 99.5 
Multiplicity 3.1 3.3
Rwork 0.243
Rfree (5.21% of reflections) 
 
0.279
R.m.s. deviations:  
                 Bond Length (Å) 
                 Bond Angle (deg) 
                 Chiral volume (Å) 
 
0.0077 
1.2072 
0.0785 
Average B factor (Å2) 74.0 
Ramachandran plot:   Core (%) 
                                 Allowed (%) 
                                  Outliers (%) 
90.8 
9.2 
0 
 756 
  757 
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Videos  758 
Video 1. Morphing of the Mos1 transposase conformation in the pre-TS cleavage PEC (PDB ID: 4U7B) 759 
into the Mos1 STC conformation. Related to Figure 9. 760 
 761 
Video 2. Morphing of the Mos1 transposase conformation in the post-cleavage PEC (PDB ID: 3HOS) 762 
into the Mos1 STC conformation. Related to Figure 9. 763 
  764 
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Supplemental Information  765 
 766 
Supplemental Figures 767 
 768 
Figure 2 – figure supplement 1. Stereo views of the difference electron density after molecular 769 
replacement. The Fo-Fc electron density (at 2.3σ) is plotted as a pink mesh with the molecular 770 
replacement model: the Mos1 PEC structure (3HOS, chains A to F). (a) Full view of one Mos1 PEC 771 
molecule, and (b) close-up view of the catalytic domains and the TSs. Transposase subunits (chains A and 772 
B) are shown as ribbons and the IR DNA duplexes (chains C to F) as ladders.  773 
 774 
Figure 2 – figure supplement 2. Packing arrangement and DNA interactions in the Mos1 STC crystal 775 
lattice. Four copies of the Mos1 STC are shown. The 5' end of each target DNA strand has a 4 nt 776 
overhang, with the self-complementary sequence GGCC, which base pairs with a symmetry related 777 
overhang in an adjacent STC molecule.  778 
 779 
Figure 2–figure supplement 3. Schematic depiction of the interactions between transposase and DNA 780 
in the Mos1 STC structure. The IR DNA is shown in blue, and the target DNA shown in black (top strand) 781 
and magenta (bottom strand). Lines connect the detailed description of the interaction to either a circle 782 
(denoting a backbone phosphate) or the central rectangle (representing a base). Transposase 783 
interactions with the backbone phosphates of nucleotides surrounding the TA target sequence support 784 
the target DNA conformation, and include contacts between the backbone amides of Y276 and N250 and 785 
C-1; Y276 OH and G-2; T213 HG1 and A4; A216 NH and G5 and R257 NH and T6. 786 
 787 
Figure 3–figure supplement 1. Strand transfer assay comparing the activity of T216A and H122A/T216A 788 
Mos1 transposases. (a) Denaturing PAGE of the strand transfer reaction products. Lanes 1 and 6 contain 789 
markers; lane 2 is without transposase; lane 3 has no target DNA, but integration occurs at the two TA 790 
dinucleotides within the IR DNA sequence.  (b) Quantification of the 40 nt and 68 nt strand transfer 791 
products for each mutant transposase, as a percentage of total DNA.   792 
 793 
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Figure 9–figure supplement 1. Structural comparison of the Mos1 STC with the post-TS cleavage Mos1 794 
paired-end complex.  The Mos1 STC (orange) is superimposed on the post-TS cleavage PEC (PDB ID: 795 
3HOS, lavender). 796 
 797 
Source Data File 798 
Figure 3–source data 1. Fluorescence decay parameters for 2AP-containing duplexes, TP13 and TP1, in 799 
the absence and presence of Mos1 transposase.  800 










